Non-suicidal self-injury (NSSI) is a complex neuropsychiatric phenotype involving emotional dysregulation, altered sensory processing, impulsivity, and social dysfunction. Existing rodent models often rely on pharmacologically induced self-injurious behavior and may not fully reproduce the spontaneous, socially embedded features observed in patients.
The study by Zhang et al. characterized spontaneous self-injurious behavior (SIB) in rhesus macaques using integrated behavioral, neuroendocrine, metabolomic, and neuroimaging assessments. Because macaques share more than 93% genetic homology with humans and possess homologous prefrontal and limbic systems, this model may support translational research in neuropsychiatric drug development.
Analysis of the Core Content of Literature
model building
The investigators identified 10 spontaneously self-injurious macaques within an established nonhuman primate colony. Five animals primarily exhibited hand-biting, while the other five exhibited leg-biting. Mean wound scores ranged from 3 to 58, and a single SIB episode lasted 1.50 ± 0.22 s on average.
SIB occurred in repetitive clusters. Approximately 10% of aggression events occurred before SIB onset, suggesting that some self-directed behavior may follow redirected aggression or acute arousal.
The study combined:
- 3-dimensional deep-learning behavioral recognition
- Social interaction and human intruder tests
- Spatial working memory and reversal learning
- Plasma cortisol, serotonin, and oxytocin assays
- Cerebrospinal fluid metabolomics
- Structural MRI, diffusion MRI, and resting-state fMRI
- Low-dose ketamine intervention
Key end point
The principal efficacy-relevant endpoints included spontaneous SIB frequency, episode duration, wound score, locomotor activity, social interaction, sensory and pain responses, cognitive performance, neuroendocrine biomarkers, metabolomic pathways, and brain structure and connectivity.
Compared with controls, SIB macaques showed lower daily activity, including significantly lower maximum vector-magnitude counts (P = 0.03) and activity counts per bout per hour (P = 0.04). Morning SIB was more pronounced, with longer duration (P = 0.011) and higher frequency (P = 0.027) than in the afternoon.
Cognitive impairment was also detected. SIB macaques required more sessions to reach the spatial working memory criterion at B = 0 s (P = 0.001). At B = 3 s, performance was significantly lower at delay times of 3, 6, 9, 12, and 15 s, with corresponding P values of 0.034, 0.024, 0.021, 0.005, and 0.028.
Important discovery
The study identified a multidimensional phenotype relevant to translational neuroscience:
- Behavioral changes: reduced locomotion, reduced social interaction, impaired defensive responses, and abnormal exploratory behavior.
- Sensory and cognitive changes: impaired sensory function, reduced pain sensitivity, deficits in spatial working memory, and slower reversal learning.
- Neuroendocrine changes: significantly lower plasma cortisol (P = 0.003) and serotonin (P = 0.046), with a trend toward lower oxytocin.
- Metabolomic changes: 969 metabolites were detected, including 30 differential metabolites: 20 down-regulated and 10 up-regulated. Dopaminergic synapse activity and phosphatidylinositol signaling were down-regulated, while carbohydrate digestion pathways were up-regulated.
- Structural brain changes: enlarged amygdala (P = 0.002), enlarged midbrain (P = 0.002), enlarged ventricles (P < 0.001), and reduced whole-brain gray matter volume (P = 0.010). Frontal-lobe gray matter was reduced (P = 0.017).
- Connectivity changes: structural connectivity was stronger between the parietal and occipital lobes (P = 0.001) and between the frontal lobe and subcortical structures (P = 0.005). Resting-state functional connectivity was higher between frontal and parietal lobes (uncorrected P = 0.005).
- Pharmacological result: ketamine administered at 1.0 mg/kg, twice weekly for 3.5 weeks, did not improve wound scores, behavior, body weight, cortisol, serotonin, or oxytocin.
Limitation of methodology and supplement of Prisys's practice
The study provides a valuable translational framework, but several limitations should be considered. The SIB cohort was small, with some behavioral and neuroimaging comparisons involving only 3 SIB macaques and 3 control macaques. Observation of biological rhythm lasted only 3 consecutive days, and the transfer to a novel environment may have influenced behavior. In addition, animal models cannot reproduce the subjective intent associated with human NSSI.
For drug development, these limitations emphasize the need for standardized phenotyping, longitudinal monitoring, and predefined efficacy criteria. At Prisys Biotech, NHP studies can be strengthened through:
- Quantitative behavioral phenotyping, including automated video analysis, activity monitoring, social interaction scoring, and longitudinal assessment of SIB frequency, duration, and wound severity.
- Integrated translational endpoints, combining clinical pathology, neuroendocrine biomarkers, pharmacokinetics, pharmacodynamics, MRI-based imaging, and tissue or biofluid biomarker analysis within a controlled study design.
These capabilities can help sponsors distinguish spontaneous behavioral variability from treatment-related effects and improve the interpretability of NHP efficacy data.
Practical significance for drug research and development
This work demonstrates that spontaneous SIB in rhesus macaques may serve as a phenotype-based NHP model for evaluating therapies targeting emotional regulation, impulsivity, sensory processing, cognition, and corticolimbic circuitry.
For pharmaceutical programs, the model may be particularly useful when endpoints are selected according to mechanism of action. A serotonergic or stress-axis intervention may require cortisol and serotonin profiling, while a CNS therapy targeting executive control may benefit from spatial working memory, reversal learning, structural MRI, and resting-state connectivity endpoints.
The absence of efficacy with low-dose ketamine also illustrates an important translational principle: a drug with clinical activity in a defined patient population may not produce the same response in an NHP cohort lacking the corresponding disease-associated phenotype. Careful subject selection, baseline stratification, route and dose optimization, and longitudinal pharmacodynamic monitoring are therefore essential.
Overall, spontaneous SIB macaques should be regarded as a model of specific translational endophenotypes rather than a complete reproduction of human NSSI. When combined with rigorous behavioral quantification and multimodal biomarker analysis, the model can support mechanism-based screening and preclinical proof-of-concept studies.
references
Zhang Y-L, Qiao Y-C, Ji Y-C, et al. A Study of Spontaneous Self-Injurious Behavior and Neuroimaging in Rhesus Macaques. doi: 10.34133/research.0782
To discuss study design, biomarker strategy, and translational efficacy assessment, contact Prisys Biotech for customized NHP neuropsychiatric drug efficacy evaluation and integrated behavioral–neuroimaging services.
